Publication | Open Access

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

AsthmaAllergyParallel-group TrialAllergy MedicineClinical TrialsPediatricsPediatric Lung DiseasePulmonary MedicineEosinophilic DisorderMedicineExacerbation-prone Eosinophilic AsthmaUrban Children